Project Details
Description
A Phase II Study of Milataxel (TL139)Administered Orally in Patients with malignant Mesothelioma
| Status | Finished |
|---|---|
| Effective start/end date | 4/1/08 → 4/30/10 |
Funding
- TAXOLOG, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.